X-40623602-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001195522.3(MPC1L):c.37G>A(p.Asp13Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000164 in 1,094,329 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 8/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001195522.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPC1L | NM_001195522.3 | c.37G>A | p.Asp13Asn | missense_variant | 1/1 | ENST00000423387.4 | NP_001182451.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPC1L | ENST00000423387.4 | c.37G>A | p.Asp13Asn | missense_variant | 1/1 | NM_001195522.3 | ENSP00000489748 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000713 AC: 8AN: 112270Hom.: 0 Cov.: 24 AF XY: 0.0000581 AC XY: 2AN XY: 34412
GnomAD4 exome AF: 0.0000102 AC: 10AN: 982059Hom.: 0 Cov.: 29 AF XY: 0.00000967 AC XY: 3AN XY: 310157
GnomAD4 genome AF: 0.0000713 AC: 8AN: 112270Hom.: 0 Cov.: 24 AF XY: 0.0000581 AC XY: 2AN XY: 34412
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.37G>A (p.D13N) alteration is located in exon 1 (coding exon 1) of the MPC1L gene. This alteration results from a G to A substitution at nucleotide position 37, causing the aspartic acid (D) at amino acid position 13 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at